Landscapes / Companies

Beijing Mabworks Biotech Co., Ltd. not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
Phase 3
Next date
MBS314, Phase 1/2 trial completes
Drugs
5
in active trials · 9 in all
Trials
8 active
18 since 2021

Drugs5

DrugHow it worksPartnerStageNext dateDetails
—
Phase 3 Dec 2028Phase 3 trial completes
—
Phase 1/2 Dec 2027Phase 1/2 trial completes
—
Phase 1/2 Jun 2028Phase 1/2 trial completes
—
Phase 1/2 —
—
Phase 1 —

About

No active trial
MBS301, mil60, Recombinant Humanized Monoclonal Antibody MIL93, Recombinant Humanized Monoclonal Antibody MIL95
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021

Follow Beijing Mabworks Biotech Co., Ltd.

Following is part of Solo: you see every change to Beijing Mabworks Biotech Co., Ltd. the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in